Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: RNA based gene-fusion analysis in FOLLICULAR NODULAR DISEASE

PROVIDER: PRJNA955922 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24180060_1.fastq.gz	Fastqsanger.gz
	SRR24180060_2.fastq.gz	Fastqsanger.gz
	SRR24180061_1.fastq.gz	Fastqsanger.gz
	SRR24180061_2.fastq.gz	Fastqsanger.gz
	SRR24180062_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Project description:RNA-based gene fusion analysis in Hyperthyroidism

| PRJNA956540 | ENA

Project description:Genomic Profiling of Follicular Nodular Disease using Next Generation Sequencing

| PRJNA950201 | ENA

Project description:DNA Sequencing and RNA Fusion Gene Analysis in Follicular Thyroid Cancer

| PRJNA901638 | ENA

Project description:RNA based Fusion gene analysis of Medullary Thyroid Cancer

| PRJNA954389 | ENA

Project description:RNA-based transcriptomic gene fusion analysis in Hashimoto's thyroiditis

| PRJNA956285 | ENA

Transcription profiling of human thyroid gland cells to find molecular signatures of thyroid follicular neoplasia

Project description:Sixty-nine (69) tumor samples were collected from patients who underwent thyroidectomy.<br><br>The tumors included 22 benign follicular adenomas, 18 follicular carcinomas, 12 samples of microfollicular adenomas, 4 anaplastic carcinomas, 2 papillary carcinomas, and 9 nodular goiters. 23 samples were obtained from the expression profile repository, Array Express, these counted 14 papillary carcinomas and 9 normal thyroid.

2010-08-05 | E-MEXP-2442 | biostudies-arrayexpress

Molecular patterns of diffuse and nodular parathyroid hyperplasia in long-term hemodialysis

Project description:Secondary hyperparathyroidism is well known complication manifested in end-stage renal disease (ESRD). Both nodular and diffuse parathyreoid hyperplasia occur in ESRD patients. Distinct molecular mechanisms involved in parathyreoid hyperplasia remain poorly understood. Microarray screening proved homogeneity of gene transcripts in hemodialysis patients as compared to transplant cohort and primary hyperparathyreoidism, therefore further studies were performed in hemodialysis patints only. Enrichment analysis conducted on 485 differentially expressed genes between nodular and diffuse parathyreoid hyperplasia revealed highly significant differences in GO terms and KEGG database in ribosome structure (p=3.70-18). Next, RT-qPCR validation of microarray analysis proved higher expression of RAN guanine nucleotide release factor (RANGRF, p<0.001), calcyclin binding protein (CACYBP, p<0.05) and exocyst complex component 8 (EXOC8, p<0.05) and lower expression of peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (PIN1, p<0.01) mRNA in nodular hyperplasia. Multivariate analysis revealed RANGRF and PIN1 expression along with parathyroid weight to be associated with nodular hyperplasia. Higher expression of genes associated with ribosomal structure and function underline extended translation mechanisms involved in parathyreoid nodular formation in long-term hemodialysis treated patients.

2015-12-12 | GSE75886 | GEO

Project description:RNA-based Fusion Gene Analysis of Adenomatous Goiter using Next Generation Sequencing

| PRJNA960692 | ENA

RNA-based fusion panel

Project description:RNA-based fusion panel

| OEX00016859 | NODE

Clinical, histopathologic and molecular features of idiopathic and diabetic nodular mesangial sclerosis in humans

Project description:Idiopathic nodular mesangial sclerosis, also called idiopathic nodular glomerulosclerosis (ING) is a rare clinical entity with unclear pathogenesis. The hallmark of this disease is the presence of nodular mesangial sclerosis on histology without clinical evidence of diabetes mellitus or other predisposing diagnoses. To achieve insights into its pathogenesis, we queried the clinical, histopathologic and transcriptomic features of ING and nodular diabetic nephropathy (DN)

2020-12-09 | GSE162830 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data